{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:01:50Z","timestamp":1790737310834,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1681\/asn.2013070798","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T23:07:06Z","timestamp":1385075226000},"page":"687-692","source":"Crossref","is-referenced-by-count":86,"title":["Feasibility of Repairing Glomerular Basement Membrane Defects in Alport Syndrome"],"prefix":"10.1681","volume":"25","author":[{"given":"Xiaobo","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloriosa","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20230208","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.yexcr.2012.02.031","article-title":"The glomerular basement membrane.","volume":"318","author":"Miner","year":"2012","journal-title":"Exp Cell Res"},{"key":"R2-10-20230208","first-page":"S69","article-title":"Alport syndrome.","volume":"58","author":"Kashtan","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"R3-10-20230208","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1681\/ASN.2008101086","article-title":"Cellular origins of type IV collagen networks in developing glomeruli.","volume":"20","author":"Abrahamson","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R4-10-20230208","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0002-9440(10)65063-8","article-title":"Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.","volume":"156","author":"Heidet","year":"2000","journal-title":"Am J Pathol"},{"key":"R5-10-20230208","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen.","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-10-20230208","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"R7-10-20230208","first-page":"751","article-title":"Renal disease in carrier female dogs with X-linked hereditary nephritis. Implications for female patients with this disease.","volume":"139","author":"Baumal","year":"1991","journal-title":"Am J Pathol"},{"key":"R8-10-20230208","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.ki.5002115","article-title":"Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis.","volume":"71","author":"Cosgrove","year":"2007","journal-title":"Kidney Int"},{"key":"R9-10-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9975(97)80016-3","article-title":"Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor.","volume":"117","author":"Grodecki","year":"1997","journal-title":"J Comp Pathol"},{"key":"R10-10-20230208","doi-asserted-by":"crossref","first-page":"436046","DOI":"10.5402\/2012\/436046","article-title":"Safety and efficacy of the ACE-inhibitor ramipril in Alport syndrome: The double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport Trial in Pediatric patients.","volume":"2012","author":"Gross","year":"2012","journal-title":"ISRN Pediatr"},{"key":"R11-10-20230208","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome.","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev"},{"key":"R12-10-20230208","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","article-title":"Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): Implications for Alport syndrome.","volume":"135","author":"Miner","year":"1996","journal-title":"J Cell Biol"},{"key":"R13-10-20230208","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0002-9440(10)64802-X","article-title":"Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.","volume":"157","author":"Cosgrove","year":"2000","journal-title":"Am J Pathol"},{"key":"R14-10-20230208","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2353\/ajpath.2006.050896","article-title":"Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.","volume":"169","author":"Rao","year":"2006","journal-title":"Am J Pathol"},{"key":"R15-10-20230208","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pmed.0030100","article-title":"Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.","volume":"3","author":"Zeisberg","year":"2006","journal-title":"PLoS Med"},{"key":"R16-10-20230208","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/labinvest.3700715","article-title":"Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease.","volume":"88","author":"Lebleu","year":"2008","journal-title":"Lab Invest"},{"key":"R17-10-20230208","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1681\/ASN.2004100871","article-title":"Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.","volume":"16","author":"Ninichuk","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R18-10-20230208","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/path.2505","article-title":"Ccl2\/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy.","volume":"218","author":"Clauss","year":"2009","journal-title":"J Pathol"},{"key":"R19-10-20230208","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1073\/pnas.0601436103","article-title":"Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.","volume":"103","author":"Sugimoto","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-10-20230208","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2009010123","article-title":"Stem cell therapies benefit Alport syndrome.","volume":"20","author":"LeBleu","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R21-10-20230208","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1634\/stemcells.2006-0201","article-title":"Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.","volume":"24","author":"Prodromidi","year":"2006","journal-title":"Stem Cells"},{"key":"R22-10-20230208","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1681\/ASN.2007070829","article-title":"Irradiation prolongs survival of Alport mice.","volume":"19","author":"Katayama","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R23-10-20230208","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ndt\/gfn722","article-title":"Stem cell therapy for Alport syndrome: The hope beyond the hype.","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R24-10-20230208","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1681\/ASN.2011030243","article-title":"Injection of amniotic fluid stem cells delays progression of renal fibrosis.","volume":"23","author":"Sedrakyan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R25-10-20230208","first-page":"21","article-title":"Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.","volume":"3","author":"Heikkila","year":"1996","journal-title":"Gene Ther"},{"key":"R26-10-20230208","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0002-9440(10)63520-1","article-title":"A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-\/- Alport mice.","volume":"163","author":"Heidet","year":"2003","journal-title":"Am J Pathol"},{"key":"R27-10-20230208","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/nar\/gni051","article-title":"Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.","volume":"33","author":"Belteki","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"R28-10-20230208","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1681\/ASN.V1481998","article-title":"Inducible podocyte-specific gene expression in transgenic mice.","volume":"14","author":"Shigehara","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R29-10-20230208","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.1092436","article-title":"Defining the epithelial stem cell niche in skin.","volume":"303","author":"Tumbar","year":"2004","journal-title":"Science"},{"key":"R30-10-20230208","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1681\/ASN.V133788","article-title":"Glomerular-specific gene excision in vivo.","volume":"13","author":"Eremina","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R31-10-20230208","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/sj.gt.3302780","article-title":"Optimization of the Tet-On system for regulated gene expression through viral evolution.","volume":"13","author":"Zhou","year":"2006","journal-title":"Gene Ther"},{"key":"R32-10-20230208","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2009091004","article-title":"Maintenance of glomerular filtration barrier integrity requires laminin alpha5.","volume":"21","author":"Goldberg","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R33-10-20230208","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)64892-4","article-title":"Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.","volume":"160","author":"Andrews","year":"2002","journal-title":"Am J Pathol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201404000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:24Z","timestamp":1786130604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201404000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013070798","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718184595.793527149","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718184595.793498224","asserted-by":"object"}]},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}